A Randomized Study of Tobramycin Plus Ticarcillin, Tobramycin Plus Cephalothin and Ticarcillin, or Tobramycin Plus Mezlocillin in the Treatment of Infection in Neutropenic Patients with Malignancies
- 1 January 1984
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 287 (1) , 16-23
- https://doi.org/10.1097/00000441-198401000-00004
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Randomized Comparative Trial of Three Aminoglycosides—Comparison of Continuous Infusions of Gentamicin, Aaikacin and Sisomicin Combined with Carbenicillin in the Treatment of Infections in Neutropenic Patients with MalignanciesMedicine, 1979
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978
- A comparative trial of sisomicin therapy by intermittent versus continuous infusionThe Lancet Healthy Longevity, 1977
- Mezlocillin: In Vitro Studies of a New Broad-Spectrum PenicillinAntimicrobial Agents and Chemotherapy, 1977
- CAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIAMedicine, 1976
- Amikacin therapy of infections in neutropenic patientsThe Lancet Healthy Longevity, 1975
- Therapeutic trials with tobramycinThe Lancet Healthy Longevity, 1974
- Antibiotic combinations for infections in neutropenic patients. Evaluation of carbenicillin plus either cephalothin or kanamycinCancer, 1972
- Infections in cancer patients.Results with gentamicin sulfate therapyCancer, 1972
- Pseudomonas Bacteremia in Patients with Malignant DiseasesThe Lancet Healthy Longevity, 1970